- Home
- CDIO vs AIOS Comparison
CDIO vs AIOS Comparison
Compare CDIO & AIOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDIO | AIOS |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | China |
| Employees | 9 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CDIO | AIOS |
|---|---|---|
| Price | $2.60 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.6M | 1.2M |
| Earning Date | 03-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $171,906.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.43 |
| 52 Week High | $7.91 | $0.88 |
Technical Indicators
Market Signals| Indicator | CDIO | AIOS |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 58.65 |
| Support Level | $1.26 | $0.46 |
| Resistance Level | $4.24 | $0.73 |
| Average True Range (ATR) | 0.82 | 0.10 |
| MACD | -0.39 | 0.01 |
| Stochastic Oscillator | 9.18 | 59.68 |
Price Performance
Historical ComparisonAbout CDIO Cardio Diagnostics Holdings Inc.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.